Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Transanal Endoscopic Microsurgery Versus Endoscopic Submucosal Dissection For Large Rectal Adenomas (TEMENDO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01023984
Recruitment Status : Suspended (scarce interest of centres)
First Posted : December 2, 2009
Last Update Posted : July 25, 2018
Sponsor:
Information provided by (Responsible Party):
Alberto Arezzo, European Association for Endoscopic Surgery

Brief Summary:

Objective: Recent non-randomized studies suggest that extended endoscopic submucosal dissection (ESD) is equally effective in removing large rectal adenomas as transanal endoscopic microsurgery (TEM). If equally effective, ESD might be a more cost-effective approach as this strategy does not require expensive equipment, general anesthesia and hospital admission. Furthermore, ESD appears to be associated with fewer complications. In a randomized trial we will compare the cost-effectiveness and cost-utility of TEM and ESD for the resection of large rectal adenomas.

Study design: 15 centers will participate in this multicenter randomized trial comparing TEM versus ESD.

Study population: Patients with a large rectal adenoma (≥2cm), located between 2 and 15 cm from the anal verge. Invasive cancer is excluded by histopathology and endoscopic ultrasonography. Patients must be in a health condition that permits general anesthesia.

Interventions: Patients will be randomized between

a. TEM: under general anesthesia b. ESD under sedation

  1. a TEM tube will be inserted in the rectum. With specialized instruments the adenoma will be dissected en bloc by a full thickness excision, after which the patient will be admitted to the hospital.
  2. an endoscope will be inserted into the rectum and the submucosa underneath the lesion will be injected with saline to lift the adenoma. With an endoscopic knife (Insulated Tip Knife, Olympus or Water Jet, Erbe) the lesion will be resected through the submucosal plane in an eb-bloc fashion, after which the patient will be observed for at least 24h in-hospital.

Primary Endpoint: incidence of recurrence at 12 months

Secondary Endpoints:

morbidity, subdivided into major (requiring surgery) and minor (requiring endoscopic or medical intervention) anorectal function. disease specific and general quality of life; number of days not spent in hospital from initial treatment until 2 years afterwards; adenoma

Sample size: Assuming a comparable baseline recurrence rate for TEM and ESD of 6% and considering an upper limit of 10% for ESD to be non-inferior (beta-error 0.2 and one-sided alpha-error 0.05), 60 patients are needed per group. These numbers provide sufficient power to reveal relevant differences in expected morbidity and in number of days not spent in hospital.

Economic evaluation: A cost-effectiveness and cost-utility analysis of ESD against TEM for large rectal adenomas from a societal perspective with respectively the costs per recurrence free patient and the cost per quality adjusted life year as primary outcome measures.


Condition or disease Intervention/treatment Phase
RECTAL NEOPLASMS Procedure: TEM - Transanal Endoscopic Microsurgery Procedure: ESD - Endoscopic Submucosal Dissection Phase 4

  Show Detailed Description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 120 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Study Start Date : January 2012
Estimated Primary Completion Date : December 2019
Estimated Study Completion Date : December 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Endoscopy

Arm Intervention/treatment
Active Comparator: TEM - Transanal Endoscopic Microsurgery
TEM under general anesthesia
Procedure: TEM - Transanal Endoscopic Microsurgery
TEM tube will be inserted in the rectum. With specialized instruments the adenoma will be dissected en bloc by a full thickness excision, after which the patient will be admitted to the hospital.

Active Comparator: ESD - Endoscopic Submucosal Dissection
ESD under sedation
Procedure: ESD - Endoscopic Submucosal Dissection
an endoscope will be inserted into the rectum and the submucosa underneath the lesion will be injected with saline to lift the adenoma. With an endoscopic knife (Insulated Tip Knife, Olympus or Water Jet, Erbe) the lesion will be resected through the submucosal plane in an eb-bloc fashion, after which the patient will be observed for at least 24h in-hospital.




Primary Outcome Measures :
  1. Incidence of recurrence at 12 months [ Time Frame: 12 months ]

Secondary Outcome Measures :
  1. Morbidity, subdivided into major (requiring surgery) and minor (requiring endoscopic or medical intervention) [ Time Frame: 24 months ]
  2. Anorectal function [ Time Frame: 12 months ]
  3. Disease specific and general quality of life [ Time Frame: 12 months ]
  4. Number of days not spent in hospital from initial treatment until 2 years afterwards [ Time Frame: 12 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Diagnosed with a large non-pedunculated rectal adenoma (sessile or flat) with a largest diameter of ≥2 cm (estimated by an opened resection snare of 20 or 30 mm).
  2. The lower and upper borders of the adenoma are located at ≥2 cm and ≤15 cm from the anal verge, respectively.
  3. Biopsies of the lesion did not show malignant neoplastic tissue on histopathological evaluation; only lesions with low or high grade dysplasia are suitable for inclusion.
  4. During flexible video endoscopy there are no signs of endoscopic suspicion for submucosal invasive cancer (Kudo pit pattern type V; excavated/depressed type morphology; fold convergence; or large smooth nodule >1 cm in a flat lesion) (33). In case of doubt, patients will undergo EUS as described at (2).
  5. In case doubt remains after flexible video endoscopy, endoscopic ultrasonography (EUS) of the rectal adenoma should exclude invasion into the submucosal layer and exclude pathological lymphadenopathy (lymph nodes >1 cm). When pathological lymph nodes are present, fine needle aspiration will be performed to exclude lymph node metastasis (N+ disease).
  6. If not performed already, total colonoscopy will be done to detect and remove all synchronous colonic adenomas or cancers first. Cecal intubation must be confirmed by identification of the appendiceal orifice and ileocecal valve.
  7. The general health condition of the patient permits general anesthesia (ASA- classification I-III).
  8. Absence of non-correctable coagulopathy (international normalized ratio >1,5, or platelet count <90 × 109/l).
  9. Patient age of 18 years or older.

Exclusion Criteria:

  1. Preoperative histologically detected malignancy
  2. Previous anorectal surgery
  3. Contraindications to general anaesthesia

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01023984


Locations
Layout table for location information
Italy
University of Torino
Torino, TO, Italy, 10126
Sponsors and Collaborators
European Association for Endoscopic Surgery
Investigators
Layout table for investigator information
Study Chair: Mario Morino, Prof of Surgery University of Torino

Publications:
Layout table for additonal information
Responsible Party: Alberto Arezzo, Assistant Professor of Surgery, European Association for Endoscopic Surgery
ClinicalTrials.gov Identifier: NCT01023984     History of Changes
Other Study ID Numbers: EAES-2
First Posted: December 2, 2009    Key Record Dates
Last Update Posted: July 25, 2018
Last Verified: July 2018

Keywords provided by Alberto Arezzo, European Association for Endoscopic Surgery:
RECTAL NEOPLASMS

Additional relevant MeSH terms:
Layout table for MeSH terms
Rectal Neoplasms
Neoplasms
Colorectal Neoplasms
Intestinal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Digestive System Diseases
Gastrointestinal Diseases
Intestinal Diseases
Rectal Diseases